Cells in the brain's immune system can act as "accelerators" and "brakes" for anxiety, opening the door to new treatments for ...
Down syndrome results in changes to the structure and function of neural circuits in the brain. Delivering a specific protein ...
The “Make America Healthy Again” movement, led by U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., is getting pushback from seed oil companies. Kennedy has repeatedly warned that ...
This study presents valuable findings on the role of KLF6 in in vitro endothelial cells exposed to altered (high or low) shear stress with a customized microfluidic device to investigate mechanisms of ...
Scientists at the Research Institute for Farm Animal Biology (FBN) in Dummerstorf and the University of Udine have detected the uptake of nanoplastics in farm animal cell cultures. The results provide ...
Hosted on MSN
Cell C’s merger deal with Blue Label’s CEC approved
Blue Label holds a non-controlling 49.5% stake in Cell C. (Photograph by Lesley Moyo) The Competition Tribunal has unconditionally approved the proposed merger in which Cell C will acquire Comm ...
MiROM identifies proteins by using mid-infrared light to detect molecular vibrations – essentially the natural “dance” of molecules within protein structures. Unlike optical spectroscopy, which ...
July 2 (Reuters) - Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress, opens new tab underway in London. Using a ...
The U.S. Food and Drug Administration (FDA) approved label updates for Bristol Myers Squibb & Co.’s (NYSE:BMY) CAR T cell therapies, Breyanzi (lisocabtagene maraleucel; liso-cel) for large B cell ...
Scientists in Tokyo have developed a groundbreaking, label-free method to identify aging human cells using electric fields. This new technique avoids the downsides of chemical tagging, which can ...
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback